3.81

5.36% -0.20

Sight Sciences Inc (SGHT)

Overview News Price History Option Chain Financials Why SGHT Down? Discussions Forecast

Sight Sciences Inc stock is traded at $3.81, with a volume of 136.56K. It is down -5.36% in the last 24 hours and down -31.37% over the past month. Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Previous Close:

$4.01

Open:

$3.94

24h Volume:

136.56K

Relative Volume:

0.44

Market Cap:

$204.95M

Revenue:

$77.36M

Net Income/Loss:

$-38.43M

P/E Ratio:

-5.1431

EPS:

-0.7408

Net Cash Flow:

$-29.92M

1W Performance:

-29.85%

1M Performance:

-31.37%

6M Performance:

+4.83%

1Y Performance:

+36.02%

1-Day Range:

$3.73

$3.945

1-Week Range:

$3.57

$4.8674

52-Week Range:

$2.03

$9.2362

Sight Sciences Inc Stock (SGHT) Company Profile

Name

Sight Sciences Inc

Sector

Healthcare (1117)

Industry

Medical Devices (139)

Phone

(415) 889-0550

Address

4040 CAMPBELL AVE,, MENLO PARK

Employee

186

Twitter

Next Earnings Date

2025-03-05

Latest SEC Filings

SGHT's Discussions on Twitter

Compare SGHT vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SGHT Sight Sciences Inc	3.795	216.56M	77.36M	-38.43M	-29.92M	-0.7408
ABT Abbott Laboratories	110.21	192.10B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	343.37	137.25B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	89.00	115.41B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	68.86	103.81B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	84.64	49.82B	6.07B	1.06B	1.34B	1.8063

Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-05-26	Upgrade	Piper Sandler	Neutral → Overweight
Aug-08-25	Upgrade	Lake Street	Hold → Buy
Dec-06-24	Initiated	UBS	Buy
Nov-04-24	Downgrade	Lake Street	Buy → Hold
Aug-21-24	Initiated	Lake Street	Buy
Sep-12-23	Downgrade	BofA Securities	Neutral → Underperform
Sep-12-23	Downgrade	Piper Sandler	Overweight → Neutral
Sep-12-23	Downgrade	William Blair	Outperform → Mkt Perform
Aug-24-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jul-10-23	Downgrade	Citigroup	Buy → Neutral
Jan-06-23	Upgrade	Stifel	Hold → Buy
Oct-04-22	Initiated	Needham	Hold
Jul-26-22	Initiated	Stifel	Hold
Feb-03-22	Initiated	William Blair	Outperform
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight

View All

Sight Sciences Inc Stock (SGHT) Latest News

Mar 09, 2026

Stock Report: Can Sight Sciences Inc weather a recession2025 Volume Leaders & Low Volatility Stock Suggestions - baoquankhu1.vn

Mar 07, 2026

Mar 06, 2026